Latest news
Latest news
Deal's flexibility feature is rare in the asset class
Fitch has replaced Moody's as main rater
Agar previously worked at Guggenheim Securities
More articles
More articles
-
Seven deals priced Tuesday, with several more winding through the visible pipeline -
Up to 18 deals expected with market likely to push through religious holidays
-
The move will take effect in late November
-
Fintech for elective medical loans saw one tranche of its debut deal up to 13 times oversubscribed
-
The $500m deal is back in premarketing after getting caught in the summer volatility
-
The deal was increased from $250m to $400m on the back of strong demand
-
Primary activity ticks over even though the pace is slower than before the last FOMC
-
A San Francisco-based fintech that arrange unsecured loans for elective medical procedures seeks debut
-
Both senior notes on solar ABS oversubscribed as issuer offers two different amortization profiles
